ClinicalTrials.Veeva

Menu

Robotic Sacrocolpopexy and Sacrocervicopexy - an Observational Study to Confirm the Peri- and Postoperative Safety and Clinical Performance (SPARO)

D

Distalmotion

Status

Enrolling

Conditions

Sacrocolpopexy

Treatments

Device: sacrocolpopexy or sacrocervicopexy

Study type

Observational

Funder types

Industry
Other

Identifiers

NCT07031050
2024-03

Details and patient eligibility

About

This study aims to confirm the perioperative and early postoperative safety and clinical performance (efficacy) of the Dexter Robotic System, in patients undergoing robotic-assisted sacrocolpopexy or sacrocervicopexy.

Enrollment

50 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Aged > 18 years
  • Women with symptomatic stage I or greater pelvic organ prolapse (POP-Q)
  • Patient agrees to perform the 6-week follow-up assessment as per Standard of Care

Exclusion criteria

  • Any planned non-urogynaecological concomitant procedures
  • History of previous POP surgery, with the exception of transvaginal approaches without mesh implantation
  • Previous surgery and/or radiation for urologic, gastrointestinal or gynecologic cancer
  • History of Crohn's disease
  • Chronic colitis

Trial contacts and locations

6

Loading...

Central trial contact

Pascal Lehmann

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems